Nurse Practitioner, Family · Fremont, CA
NPI
1629490362
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2557 Mowry Ave, Suite 25
Fremont, CA, 94538
Phone (855) 717-1755
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$234K
1,591 prescriptions
Company payments, 2025
$2,676
From 21 companies
Medicare prescription drug claims, 2024
In 2024, the drug Olivia D Martinez prescribed most often to Medicare patients was Triamcinolone Acetonide, with 252 prescriptions and refills. In total Olivia D Martinez wrote 1,591 Medicare prescriptions that cost $234K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-07.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Triamcinolone Acetonide Generic | 252 | 267 | 112 | $2,904 |
| Hydrocortisone Generic | 161 | 163 | 80 | $698 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 149 | 154 | 46 | $9,107 |
| Ketoconazole Generic | 136 | 145 | 52 | $2,759 |
| Fluocinonide Generic | 114 | 125 | 49 | $5,669 |
| Selenium Sulfide Generic | 95 | 112 | 31 | $1,549 |
| Clobetasol Propionate Generic | 74 | 82 | 36 | $7,673 |
| Tacrolimus Generic | 72 | 75 | 43 | $9,676 |
| Calcipotriene Generic | 63 | 69 | 21 | $14K |
| Clotrimazole Generic | 53 | 53 | 27 | $594 |
| Clindamycin Phosphate Generic | 47 | 49 | 13 | $1,692 |
| Metronidazole Generic | 40 | 46 | Under 11 | $2,955 |
| Betamethasone Dipropionate Generic | 30 | 31 | 17 | $1,081 |
| Methotrexate Methotrexate Sodium | 28 | 52 | Under 11 | $492 |
| Mupirocin Generic | 22 | 22 | 18 | $129 |
Brand drugs: 117 claims; generic drugs: 1,474 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Olivia D Martinez $2,676 ($2,676 in general payments such as food, travel and fees) from 21 companies. The largest payer was Arcutis Biotherapeutics, Inc. with $330.
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | 5 | $330 |
| Pfizer Inc. PFE | 14 | $315 |
| LEO Pharma Inc. | 30 | $313 |
| Abbvie Inc. ABBV | 16 | $301 |
| UCB, Inc. UCB.BR | 22 | $261 |
| Lilly USA, LLC LLY | 9 | $249 |
| Janssen Biotech, Inc. JNJ | 8 | $171 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $142 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $126 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $68.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.